NO20033857L - Benzofenoner som inhibitorer av revers transkriptase - Google Patents

Benzofenoner som inhibitorer av revers transkriptase

Info

Publication number
NO20033857L
NO20033857L NO20033857A NO20033857A NO20033857L NO 20033857 L NO20033857 L NO 20033857L NO 20033857 A NO20033857 A NO 20033857A NO 20033857 A NO20033857 A NO 20033857A NO 20033857 L NO20033857 L NO 20033857L
Authority
NO
Norway
Prior art keywords
benzophenones
inhibitors
reverse transcriptase
transcriptase
reverse
Prior art date
Application number
NO20033857A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033857D0 (no
Inventor
Joseph Howing Chan
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20033857D0 publication Critical patent/NO20033857D0/no
Publication of NO20033857L publication Critical patent/NO20033857L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/51—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20033857A 2001-03-02 2003-09-01 Benzofenoner som inhibitorer av revers transkriptase NO20033857L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27295301P 2001-03-02 2001-03-02
PCT/US2002/006037 WO2002070470A2 (en) 2001-03-02 2002-02-28 Benzophenones as inhibitors of reverse transcriptase

Publications (2)

Publication Number Publication Date
NO20033857D0 NO20033857D0 (no) 2003-09-01
NO20033857L true NO20033857L (no) 2003-10-27

Family

ID=23041935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033857A NO20033857L (no) 2001-03-02 2003-09-01 Benzofenoner som inhibitorer av revers transkriptase

Country Status (18)

Country Link
US (2) US6995283B2 (pl)
EP (1) EP1363877A2 (pl)
JP (1) JP2004525914A (pl)
KR (1) KR100638954B1 (pl)
CN (1) CN1494528A (pl)
AR (2) AR035436A1 (pl)
AU (1) AU2002254056C1 (pl)
BR (1) BR0207752A (pl)
CA (1) CA2439820A1 (pl)
CZ (1) CZ20032366A3 (pl)
HU (1) HUP0303326A2 (pl)
IL (1) IL157348A0 (pl)
MX (1) MXPA03007883A (pl)
NO (1) NO20033857L (pl)
NZ (1) NZ527864A (pl)
PL (1) PL364658A1 (pl)
WO (1) WO2002070470A2 (pl)
ZA (1) ZA200306549B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
US7399856B2 (en) 2002-08-09 2008-07-15 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrile
EA009478B1 (ru) 2002-08-23 2008-02-28 Ардеа Байосайенсиз, Инк. Ненуклеозидные ингибиторы обратной транскриптазы
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
EP1597237B1 (en) * 2003-02-07 2016-07-27 Janssen Pharmaceutica NV Pyrimidine derivatives for the prevention of HIV infection
EP1628953A4 (en) 2003-03-27 2006-11-02 Smithkline Beecham Corp PROCESS FOR PREPARING REVERSE TRANSCRIPTASE INHIBITORS
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
EP1740550A1 (en) * 2004-04-14 2007-01-10 Pfizer Limited Sulphur-linked imidazole compounds for the treament of hiv
US20060025480A1 (en) * 2004-08-02 2006-02-02 Boehringer Ingelheim International Gmbh Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
ME01512B (me) 2004-08-25 2014-04-20 Ardea Biosciences Inc S-triazolil alfa-merkaptoacetanilida kao inhibitori HIV reversne transkriptaze
WO2007050087A1 (en) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
WO2006034583A1 (en) * 2004-09-30 2006-04-06 Boehringer Ingelheim International Gmbh & Co Kg Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
JP2008525419A (ja) * 2004-12-22 2008-07-17 ファイザー・リミテッド Hiv−1逆転写酵素の非ヌクレオシド阻害剤
MX2007012443A (es) * 2005-04-08 2007-12-13 Abbott Lab Formulaciones farmaceuticas orales que comprenden acido fenofibrico y/o sus sales.
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
TW200808694A (en) * 2006-04-17 2008-02-16 Smithkline Beecham Corp Chemical compounds
WO2007121415A2 (en) * 2006-04-17 2007-10-25 Smithkline Beecham Corporation Chemical compounds
WO2007121418A2 (en) * 2006-04-17 2007-10-25 Smithkline Beecham Corporation Chemical compounds
WO2008016522A2 (en) * 2006-07-24 2008-02-07 Gilead Sciences, Inc. Hiv reverse transcriptase inhibitors
CN101407476B (zh) * 2007-10-12 2012-07-18 中国人民解放军军事医学科学院毒物药物研究所 作为非核苷类hiv逆转录酶抑制剂的间二芳烃-多取代苯胺类化合物、其制备方法及用途
BRPI0819847B1 (pt) 2007-11-27 2022-01-11 Ardea Biosciences, Inc Compostos e composições
CN101450911B (zh) * 2007-11-30 2012-02-29 山东轩竹医药科技有限公司 被金刚烷取代的苯甲酸衍生物
CN102212022A (zh) * 2011-04-20 2011-10-12 复旦大学 二苯甲醇衍生物及其制备方法和用途
CN102219717A (zh) * 2011-04-20 2011-10-19 复旦大学 N-苯基芳基甲酰胺衍生物及其制备方法和用途
CN102206177A (zh) * 2011-04-20 2011-10-05 复旦大学 1-萘基苯甲酮衍生物及其制备方法和用途
CN110015963A (zh) * 2019-04-12 2019-07-16 上海优合生物科技有限公司 一种2-氯-6-甲基苯胺的制备方法
WO2020231979A1 (en) * 2019-05-13 2020-11-19 The Trustees Of Princeton University Small molecule inhibitors of viral replication
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03198050A (ja) * 1989-12-27 1991-08-29 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料

Also Published As

Publication number Publication date
CA2439820A1 (en) 2002-09-12
AR035436A1 (es) 2004-05-26
BR0207752A (pt) 2004-03-23
ZA200306549B (en) 2004-11-22
US20040122064A1 (en) 2004-06-24
KR20030086283A (ko) 2003-11-07
HUP0303326A2 (hu) 2004-01-28
CZ20032366A3 (en) 2004-04-14
KR100638954B1 (ko) 2006-10-25
MXPA03007883A (es) 2003-12-04
US6995283B2 (en) 2006-02-07
EP1363877A2 (en) 2003-11-26
CN1494528A (zh) 2004-05-05
PL364658A1 (pl) 2004-12-13
AU2002254056C1 (en) 2006-04-13
AU2002254056B2 (en) 2005-09-29
US20060009651A1 (en) 2006-01-12
JP2004525914A (ja) 2004-08-26
NZ527864A (en) 2004-05-28
IL157348A0 (en) 2004-02-19
NO20033857D0 (no) 2003-09-01
AR043367A2 (es) 2005-07-27
WO2002070470A2 (en) 2002-09-12
WO2002070470A3 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
NO20033857D0 (no) Benzofenoner som inhibitorer av revers transkriptase
NO20021042D0 (no) Benzofenoner som inhibitorer av revers transkriptase
NO20033593L (no) Kinazoliner som MMP-13 inhibitorer
NO20043004L (no) 4-oksokinolin forbindelse og anvendelse derav som HIV-integraseinhibitor
NO20043726L (no) Heteroarylforbindelser anvendelige som inhibitorer av GSK-3
NO20041180L (no) Pyrrolopyrimidiner som midler for inbibering av cysteinprotaser
NO20026262D0 (no) Cyklopentyl-substituerte glutaramidderivater som inhibitorer av nöytral endopeptidase
NO20030867D0 (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20043158L (no) Substituerte kinazolinderivater som inhibitorer av aurorakinaser
NO20033618L (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20041887L (no) Benzomidazoler anvendelige som proteinkinase-inhibitorer
ATE420640T1 (de) Fab-i-inhibitoren
ATE370124T1 (de) Inhibitoren dernicht-nukleosid-inhibitoren der reversen transkriptase
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
NO20042938L (no) Nitrogenholdige forbindelser som korrosjonsinhibitorer
NO20044104L (no) Ikke-nukleoside reverstranskriptase-inhibitorer
NO20050563L (no) N-aryl-piperidinsubstituerte bifenylkarboksamider som inhibitorer av apolipoprotein B-sekresjon
NO20040996L (no) Nye forbindelser og sammensetninger som catepsin-inhibitorer
DK1294720T3 (da) Non-nukleosid revers transkriptase-inhibitorer
DK1373261T3 (da) Cyklopropaheterocykler som non-nukleotid revers transkriptase-hæmmer
NO20033700L (no) Isoksazolinderivater som anti-depressive midler
NO20041909L (no) Nye forbindelser og sammensetninger som katepsin S-inhibitorer
DK1373267T3 (da) Non-nucleoside revers transkriptase-inhibitorer
NO20044043L (no) Dipyridodiazepioner som revers-transkriptase-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application